Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial.

Source:http://linkedlifedata.com/resource/pubmed/id/18077217

Download in:

View as

General Info

PMID
18077217